Effects of radiation therapy on myocardial cell integrity and pump function: Which role for cardiac biomarkers?

Chemotherapy

Volumn 56, Issue 2, 2010, Pages 147-152

  Nellessen, Ulrich ^a   Zingel, Manuela ^a   Hecker, Hartmut ^c   Bahnsen, Jens ^b   Borschke, Dorchpagma ^b  

^a Johanniter Krankenhaus Genthin Stendal GmbH   (Germany)

^b Department of Radiooncology   (United States)

^c HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Cardiac biomarkers; Heart failure; Radiation

Indexed keywords

BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; TROPONIN I;

ADULT; ARTICLE; BLOOD SAMPLING; BREAST CANCER; CANCER RADIOTHERAPY; CARDIOMYOPATHY; CELL DAMAGE; CLINICAL ARTICLE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; HEART FUNCTION; HEART INJURY; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE CELL; HIGH RISK PATIENT; HUMAN; LUNG CANCER; MALE; PATIENT CARE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RADIATION DOSE; RADIATION RESPONSE;

AGED; BIOLOGICAL MARKERS; BREAST NEOPLASMS; ECHOCARDIOGRAPHY; FEMALE; HEART; HEART FAILURE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; RADIATION DOSAGE; RADIATION INJURIES; TROPONIN I;

EID: 77952245699     PISSN: 00093157     EISSN: None     Source Type: Journal    
DOI: 10.1159/000313528     Document Type: Article

References (28)

1. Gaya AM, Ashford RFU: Cardiac complications of radiation therapy. Clin Oncol 2005; 17: 153-159.
2. Constine LS, Schwartz RG, Savage D, et al: Cardiac function, perfusion, and morbidity in irradiated long-term survivors of Hodgkin's disease. Int J Radiat Oncol Biol Phys 1997; 39: 897-906.
3. Adams MJ, Hardenbergh PH, Constine LS, et al: Radiation-associated cardiovascular disease. Crit Rev Oncol Hematol 2003; 45: 55-75.
4. Fajardo LF, Stewart JR, Cohn KE: Morphology of radiation-induced heart disease. Arch Pathol 1968; 86: 512-519.
5. Orzan F, Brusca A, Gaita F, et al: Associated cardiac lesions in patients with radiation-induced complete heart block. Int J Cardiol 1993; 39: 151-156.
6. Marti V, Garcia J, Auge JM, et al: Coronary arterial spasm and cardiac arrest following mediastinal radiation therapy for Hodgkin's disease. Chest 1991; 100: 1180-1181.
7. Paszat LF, Mackillop WJ, Groome PA, et al: Mortality from myocardial infarction after adjuvant radiotherapy for breast cancer in the surveillance, epidemiology, and end-results cancer registries. J Clin Oncol 1998; 16: 2625-2631.
8. Steele GG: Basic Clinical Radiobiology. London, Arnold Press, 1997, pp 30-39.
9. Byrd BF, Mendes LA: Cardiac complications of mediastinal radiotherapy. J Am Coll Cardiol 2003; 42: 750-751.
10. Ishii J, Nomura M, Nakamura Y, et al: Risk stratification using a combination of cardiac troponin T and brain natriuretic peptide in patients hospitalized for worsening chronic heart failure. Am J Cardiol 2002; 89: 691-695.
11. Perna ER, Macin SM, Canella JP, et al: Ongoing myocardial injury in stable severe heart failure: value of cardiac troponin T monitoring for high-risk patient identification. Circulation 2004; 110: 2376-2382.
12. Nellessen U, Goder S, Schobre R, et al: Serial analysis of troponin I levels in patients with ischemic and nonischemic dilated cardiomyopathy. Clin Cardiol 2006; 29: 219-224.
13. Hoffmann, R: Positionspapier zu Qualitätsstandards in der Echokardiographie. Z Kardiol 2004; 93: 975-986.
14. Schimmel KJM, Richel DJ, Van den Brink RBA, et al: Cardiotoxicity of cytotoxic drugs. Cancer Treat Rev 2004; 30: 181-191.
15. Swain M, Whaley FS, Ewer MS: Congestive heart failure in patients treated with doxirubicin. Cancer 2003; 97: 2869-2879.
16. Hojris I, Sand NP, Andersen J, et al: Myocardial perfusion imaging in breast cancer patients treated with or without post-mastectomy radiotherapy. Radiother Oncol 2000; 55: 163-172.
17. Bohm M: Pathophysiology of heart failure today. Herz 2002; 27: 75-91.
18. Filatov VL, Katrukha AG, Bulargina TV: Troponin: structure properties and mechanism of functioning. Biokhimiya 1999; 9: 22-45.
19. Maisel AS, Krishnaswamy P, Nowak RM, et al: Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 2002; 347: 161-167.
20. Wieczorek SJ, Wu AHB, Christenson R, et al: A rapid B-type natriuretic peptide assay accurately diagnoses left ventricular dysfunction and heart failure: a multicenter evaluation. Am Heart J 2002; 144: 834-839.
21. Kozak KR, Hong TS, Sluss PM, Lewandrowski EL, Aleryani SL, Macdonald SM, Choi NC, Yock TI: Cardiac blood biomarkers in patients receiving thoracic (chemo)radiation. Lung Cancer 2008; 62: 351-355.
22. Hughes-Davies L, Sacks D, Rescigno J, Howard S, Harris H: Serum cardiac troponin T levels during treatment of early-stage breast cancer. J Clin Oncol 1995; 13: 2582-2584.
23. Meriggi F, Di Biasi B, Zaniboni A: The renaissance of platinum-based chemotherapy for metastatic breast cancer. J Chemother 2008; 20: 551-560.
24. Correale P, Montagnani F, Miano S, Sciandivasci A, Pascucci A, Petrioli R, Testi W, Tanzini G, Francini G: Biweekly triple combination chemotherapy with gemcitabine, oxaliplatin, levofolinic acid and 5-fluorouracil (GOLF) is a safe and active treatment for patients with inoperable pancreatic cancer. J Chemother 2008; 20: 119-125.
25. Vallis K, Pintilie M, Chong N, et al: Assessment of coronary heart disease morbidity and mortality following radiation therapy for early breast cancer. J Clin Oncol 2002; 20: 1036-1042.
26. Boivin JF, Hutchison G, Lubin J, Mauch P: Coronary artery disease mortality in patients treated for Hodgkin's disease. Cancer 1992; 69: 1241-1247.
27. Hancock SL, Tucker MA, Hoppe RT: Factors affecting late mortality from heart disease after treatment for Hodgkin's disease. JAMA 1993; 270: 1949-1955.
28. Marin J, Marin E, Gutierrez-Iniguez MA, et al: Mechanisms involved in the hemodynamic alterations in congestive heart failure as a basis for a rational pharmacological treatment. Pharmacol Ther 2000; 88: 15-31.